Gout pp 187-197 | Cite as

Diagnostic Procedures in the Management of Gout

  • David S. Newcombe
Chapter

Abstract

The procedures that are necessary for accurate diagnosis of gout are discussed here. These include criteria for diagnosis, analysis of blood and synovial fluid, and the tests that are needed for the effective management of the disease.

Keywords

Cholesterol Arthritis Corticosteroid Iodine Heparin 

References

  1. 1.
    Allen DJ, Milosovich G, Mattocks AM. Inhibition of monosodium urate crystal growth. Arthritis Rheum. 1965;8:1123.PubMedCrossRefGoogle Scholar
  2. 2.
    Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15:189.PubMedCrossRefGoogle Scholar
  3. 3.
    Seegmiller JE. The acute attack of gouty arthritis. Arthritis Rheum. 1965;8:714.PubMedCrossRefGoogle Scholar
  4. 4.
    Gold GL, Fritz RD. Hyperuricemia associated with the treatment of leukemia. Ann Intern Med. 1957;62:428.Google Scholar
  5. 5.
    Kjellstrand CM, Campbell III DC, von Hartitizseh B, et al. Hyperuricemic acute renal failure. Arch Intern Med. 1974;133:349.PubMedCrossRefGoogle Scholar
  6. 6.
    Alvsaker JO. Uric acid in human plasma. V. Isolation and identification of plasma proteins interacting with urate. Scand J Clin Lab Invest. 1966;18:228.CrossRefGoogle Scholar
  7. 7.
    Alvsaker JO. Uric in human plasma. III. Investigations on the interaction between the urate ion and human albumin. Scand J Clin Lab Invest. 1965;17:467.PubMedCrossRefGoogle Scholar
  8. 8.
    Alvsaker JO. Uric acid in human plasma. IV. Investigations on the interactions between urate and the macromolecular fraction in plasma from healthy individuals and patients with diseases associated with hyperuricemia. Scand J Clin Lab Invest. 1965;17:476.PubMedCrossRefGoogle Scholar
  9. 9.
    Aakesson I, Aakesson JO. The urate-binding alpha-1-alpha-2-globulin. Isolation and characterization of the protein from human plasma. Eur J Clin Invest. 1971;1:281.PubMedCrossRefGoogle Scholar
  10. 10.
    Sletten K, Aakesson I, Alvsaker JO. Presence of ornithine in the urate-binding alpha-1-alpha-2-globulin. Nat New Biol. 1971;231:118.PubMedCrossRefGoogle Scholar
  11. 11.
    Katz WA, Ehrlich GE. The solubility of monosodium urate in serum and connective tissue fractions. Arthritis Rheum. 1968;11:492.Google Scholar
  12. 12.
    Skeikh MI, Moller JV. Binding of urate to proteins of human and rabbit plasma. Biochim Biophys Acta. 1968;158:456.CrossRefGoogle Scholar
  13. 13.
    Schumacher HR. Intracellular crystals in synovial fluid anticoagulated with oxalate. N Engl J Med. 1966;274:1372.PubMedCrossRefGoogle Scholar
  14. 14.
    Gatter RA, McCarty DJ. Synovianalysis, a rapid clinical diagnostic procedure. Rheumatism. 1964;20:2.PubMedGoogle Scholar
  15. 15.
    Tanphaechitr K, Spilberg I, Hahn B. Lithium heparin crystals simulating calcium pyrophosphate dihydrate crystals in synovial fluid. Arthritis Rheum. 1976;19:966.CrossRefGoogle Scholar
  16. 16.
    Gatter RA. A practical handbook of joint fluid analysis. Philadelphia: Lea and Febiger; 1984. p. 43.Google Scholar
  17. 17.
    Steinbrocker O, Neustadt D. Aspiration and injection therapy in arthritis and musculoskeletal diseases. Hagerstown: Harper and Row; 1972.Google Scholar
  18. 18.
    Moskowitz RW. Clinical rheumatology: a problem-oriented approach. Philadelphia: Lea & Febiger; 1975.Google Scholar
  19. 19.
    Moore GF. Arthrocentesis [computer file]/Moore, Wigden, Tape. St. Louis: Mosby; 1999.Google Scholar
  20. 20.
    Roberts WN, Hayes CW, Breitbach SA, Owen Jr DS. Dry taps and what to do about them: a pictorial essay on failed arthrocentesis of the knee. Am J Med. 1996;100:1.CrossRefGoogle Scholar
  21. 21.
    Kerolus G, Clayburne G, Schumacher Jr HR. Is it mandatory to examine synovial fluids promptly after arthrocentesis? Arthritis Rheum. 1989;32:271.PubMedCrossRefGoogle Scholar
  22. 22.
    Morrissy RT. Bone and joint infection in the neonate. Pediatr Ann. 1989;18:33.PubMedGoogle Scholar
  23. 23.
    Fink CW, Nelson JD. Septic arthritis and osteomyelitis in children. Clin Rheum Dis. 1986;12:423.PubMedGoogle Scholar
  24. 24.
    Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med. 1985;312:764.PubMedCrossRefGoogle Scholar
  25. 25.
    Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum. 1989;32:496.PubMedCrossRefGoogle Scholar
  26. 26.
    Lyon RM, Evanich JD. Culture-negative septic arthritis in children. J Pediatr Orthop. 1999;19:655.PubMedGoogle Scholar
  27. 27.
    Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum. 1991;34:141.PubMedCrossRefGoogle Scholar
  28. 28.
    Louthrenoo W, Sieck M, Clayburne G, et al. Supravital staining of cells in non-inflammatory synovial fluids: analysis of the effect of crystals on cell populations. J Rheumatol. 1991;18:409.PubMedGoogle Scholar
  29. 29.
    de Ceulaer K, Forbes M, Roper D, Serjeant GR. Non-gouty arthritis in sickle cell disease: report of 37 consecutive cases. Ann Rheum Dis. 1984;43:599.PubMedCrossRefGoogle Scholar
  30. 30.
    Krey P, Bailen D. Synovial fluid leukocytosis: a study of extremes. Am J Med. 1979;67:436.PubMedCrossRefGoogle Scholar
  31. 31.
    Shmerling RH, Delbanco TL, Tosteson AN, Trentham DE. Synovial fluid tests. What should be ordered? JAMA. 1990;264:1009.PubMedCrossRefGoogle Scholar
  32. 32.
    Horowitz MD, Abbey L, Sirota DK, Spiera H. Intraarticular noninflammatory free urate suspension (urate milk) in 3 patients with painful joints. J Rheumatol. 1996;17:712.Google Scholar
  33. 33.
    Fam AG, Reis MD, Szalai JP. Acute gouty synovitis associated with “urate” milk. J Rheumatol. 1997;25:2285.Google Scholar
  34. 34.
    Pascual E, Tovar J, Ruiz MT. The ordinary light microscope: an appropriate tool for the provisional detection and identification of crystals in synovial fluid. Ann Rheum Dis. 1989;48:983.PubMedCrossRefGoogle Scholar
  35. 35.
    Gordon C, Swann A, Dieppe P. Detection of crystals in synovial fluids by light microscopy: sensitivity and reliability. Ann Rheum Dis. 1989;48:737.PubMedCrossRefGoogle Scholar
  36. 36.
    Dieppe P, Swann A. Identification of crystals in synovial fluid. Ann Rheum Dis. 1999;38:201.Google Scholar
  37. 37.
    Segal JB, Albert D. Diagnosis of crystal-induced arthritis by synovial fluid examination for crystals: lessons from an important test. Arthritis Care Res. 1999;12:376.PubMedCrossRefGoogle Scholar
  38. 38.
    Schlesinger N, Baker DG, Schumacher HR. How well have diagnostic tests and therapies for gout been evaluated? Curr Opin Rheumatol. 1999;11:441.PubMedCrossRefGoogle Scholar
  39. 39.
    Leader R. Repeated synovial fluid analysis may be needed to find crystals in gout. Clin Rheumatol. 1998;17:549.CrossRefGoogle Scholar
  40. 40.
    Ivorra J, Rosas J, Pascual E. Most calcium pyrophosphate crystals appear as non-birefringent. Ann Rheum Dis. 1999;58:582.PubMedCrossRefGoogle Scholar
  41. 41.
    Salvi E, Manganelli S, Catenaccio M, et al. Diff Quik staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids. Ann Rheum Dis. 2001;60:194.CrossRefGoogle Scholar
  42. 42.
    Schumacher HR, Somlyo AP, Tse RL, Maurer K. Apatite crystals associated with arthritis. Ann Intern Med. 1977;87:411.PubMedGoogle Scholar
  43. 43.
    Hoffman GS, Schumacher HR, Paul H, et al. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med. 1982;97:38.Google Scholar
  44. 44.
    Langlands DR, Dawkins RL, Matz LR, et al. Arthritis associated with a crystallizing cryoprecipitable IgG paraprotein. Am J Med. 1980;68:461.PubMedCrossRefGoogle Scholar
  45. 45.
    Skinner M, Cohen AS. Calcium pyrophosphate dihydrate crystal deposition disease. Arch Intern Med. 1969;123:636.PubMedCrossRefGoogle Scholar
  46. 46.
    Zuckner J, Uddin J, Gantner GE, Dorner RW. Cholesterol crystals in synovial fluid. Ann Intern Med. 1964;60:436.PubMedGoogle Scholar
  47. 47.
    Newcombe DS, Cohen AS. Chylous synovial effusion in rheumatoid arthritis. Am J Med. 1965;38:156.PubMedCrossRefGoogle Scholar
  48. 48.
    Tourliere D, Benhamou CL. Lipid microcrystals and other rare crystals in the joints. Rev Prat. 1994;44:197.PubMedGoogle Scholar
  49. 49.
    Verbruggen LA, Bourgain C, Verbeelen D. Late presentation and microcrystalline arthropathy in primary hyperoxaluria. Clin Exp Rheumatol. 1989;7:631.PubMedGoogle Scholar
  50. 50.
    Kahn C, Hollander J, Schumacher HR. Corticosteroid crystals in synovial fluid. JAMA. 1970;211:607.CrossRefGoogle Scholar
  51. 51.
    Menard HA, de Medicis R, Lussier A, Brown J. Charcot-Leyden, not corticosteroid, crystals. Arthritis Rheum. 1983;26:1533.PubMedCrossRefGoogle Scholar
  52. 52.
    Crugnola A, Schiller A, Radin E. Polymeric debris in synovium after total hip replacement: histological identification. J Bone Joint Surg. 1977;59A:860.Google Scholar
  53. 53.
    Pascual E, Batlle-Gualda E, Martinez A, et al. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med. 2000;131:756.Google Scholar
  54. 54.
    Kennedy TD, Higgens CS, Woodrow DF, Scott JT. Crystal deposition in the knee and great toe joints of asymptomatic gout patients. J R Soc Med. 1984;77:747.PubMedGoogle Scholar
  55. 55.
    Johnson JR. Diagnosis of intercritical gout. Ann Intern Med. 2000;132:843.PubMedGoogle Scholar
  56. 56.
    Rouault T, Caldwell DS, Holmes EW. Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls. Arthritis Rheum. 1982;25:209.PubMedCrossRefGoogle Scholar
  57. 57.
    Jaccard YB, Gerster JC, Calame L. Mixed monosodium urate and calcium pyrophosphate crystal-induced arthropathy. A review of seventeen cases. Rev Rhum Engl Ed. 1996;63:331.PubMedGoogle Scholar
  58. 58.
    O’Connell PG, Milburn BM, Nashel DJ. Coexistent gout and septic arthritis: a report of two cases and literature review. Clin Exp Rheumatol. 1985;3:265.PubMedGoogle Scholar
  59. 59.
    Durback MA, Schumacher Jr HR. Acute gouty arthritis in 4 patients with systemic sclerosis. J Rheumatol. 1988;15:1503.PubMedGoogle Scholar
  60. 60.
    Rodriguez MA, Paul H, Abadi I, et al. Multiple microcrystal deposition disease in a patient with systemic lupus erythematosus. Ann Rheum Dis. 1984;43:498.PubMedCrossRefGoogle Scholar
  61. 61.
    McMillen MA, Cunningham ME, Schoen R, Fikrig E. Gout in patients with systemic lupus erythematosus. Br J Rheumatol. 1994;33:595.PubMedCrossRefGoogle Scholar
  62. 62.
    Veerapen K, Schumacher HRJ, van Linhoudt D, et al. Tophaceous gout in young patients with systemic lupus erythematosus. J Rheumatol. 1993;20:721.PubMedGoogle Scholar
  63. 63.
    DeCastro P, Jorizzo JL, Solomon AR, et al. Coexistent systemic lupus erythematosus and tophaceous gout. J Am Acad Dermatol. 1985;13:650.PubMedCrossRefGoogle Scholar
  64. 64.
    Frocht A, Leck JC, Robbins DL. Gout and hyperuricaemia in systemic lupus erythematosus. Br J Rheumatol. 1987;26:303.PubMedCrossRefGoogle Scholar
  65. 65.
    Kurita Y, Tsuboi R, Numata K, Ogawa H. A case of multiple urate deposition, without gouty attacks, in a patient with systemic lupus erythematosus. Cutis. 1989;43:273.PubMedGoogle Scholar
  66. 66.
    Kowalec JK, Krey PR. Gout in an urban setting. J Med Soc N J. 1978;75:617.PubMedGoogle Scholar
  67. 67.
    Lowenthal MN, Dymond D. Gout and hyperuricaemia in blacks. S Afr Med J. 1977;52:832.PubMedGoogle Scholar
  68. 68.
    Mody GM, Naidoo PD. Gout in South African blacks. Ann Rheum Dis. 1984;43:394.PubMedCrossRefGoogle Scholar
  69. 69.
    Mijiyawa M. Gout in patients attending the Rheumatology unit of Lome Hospital. Br J Rheumatol. 1995;34:843.PubMedCrossRefGoogle Scholar
  70. 70.
    Cassim B, Mody GM, Deenadayalu VK, Hammond MG. Gout in South Africans: a clinical and genetic study. Ann Rheum Dis. 1994;53:759.PubMedCrossRefGoogle Scholar
  71. 71.
    Soderquist B, Jones J, Fredlund H, Vikerforst T. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis. 1998;30:591.PubMedCrossRefGoogle Scholar
  72. 72.
    Arthur RE, Stern M, Galeazzi M, et al. Synovial fluid lactic acid in septic and nonseptic arthritis. Arthritis Rheum. 1983;26:1499.PubMedCrossRefGoogle Scholar
  73. 73.
    Curtis GD, Newman RJ, Slack MP. Synovial fluid lactate and the diagnosis of septic arthritis. J Infect. 1983;6:239.PubMedCrossRefGoogle Scholar
  74. 74.
    Kortekangas P, Peltola O, Toivanen A, Aro HT. Synovial-fluid D-lactic acid in bacterial and other acute joint effusions. Scand J Rheumatol. 1994;23:203.PubMedCrossRefGoogle Scholar
  75. 75.
    Wilbrink B, van der Heijden IM, Schouls LM, et al. Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum. 1998;41:2276.Google Scholar
  76. 76.
    van der Heijden IM, Wilbrink B, Schouls LM, et al. Detection of mycobacteria in joint samples from patients with arthritis using a genus-specific polymerase chain reaction and sequence analysis. Rheumatology. 1999;38:547.PubMedCrossRefGoogle Scholar
  77. 77.
    Wilkinson NZ, Kingsley GH, Jones HW, et al. The detection of DNA from a range of bacterial species with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology. 1999;38:260.PubMedCrossRefGoogle Scholar
  78. 78.
    Louie JS, Liebling MR. The polymerase chain reaction in infectious and post-infectious arthritis. A review. Rheum Dis Clin North Am. 1998;24:227.PubMedCrossRefGoogle Scholar
  79. 79.
    Jalava J, Skurnik M, Toivanen P, Eerola E. Bacterial PCR in the diagnosis of joint infection. Ann Rheum Dis. 2001;60:287.PubMedCrossRefGoogle Scholar
  80. 80.
    Kempsell KE, Cox CJ, Hurle M, et al. Reverse transcriptase-PCR analysis of bacterial rRNA for detection and characterization of bacterial species in arthritis synovial tissue. Infect Immun. 2000;68:6012.PubMedCrossRefGoogle Scholar
  81. 81.
    van der Heijden IM, Wilbrink B, Vije AE, et al. Detection of bacterial DNA in serial synovial samples obtained during antibiotic treatment from patients with septic arthritis. Arthritis Rheum. 1999;42:2198.PubMedCrossRefGoogle Scholar
  82. 82.
    Ortel RW, Newcombe DS. Acute gouty arthritis and response to colchicine in the virtual absence of synovial-fluid leukocytes. N Engl J Med. 1974;290:1363.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • David S. Newcombe
    • 1
  1. 1.WestonUSA

Personalised recommendations